JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB141523

2-Methoxyantimycin A3, Bcl-xL and Bcl-2 inhibitor

Be the first to review this product! Submit a review

|

(5 Publications)

MW 534.6 g/mol, Purity >98%. Bcl-xL and Bcl-2 inhibitor. Antiapoptotic. Depolarizes mitochrondrial membrane potential. Reduces tumor size in vivo without toxicity.
1 Images
Chemical Structure - 2-Methoxyantimycin A3, Bcl-xL and Bcl-2 inhibitor (AB141523)
  • Chemical Structure

Lab

Chemical Structure - 2-Methoxyantimycin A3, Bcl-xL and Bcl-2 inhibitor (AB141523)

2D chemical structure image of ab141523, 2-Methoxyantimycin A3, Bcl-xL and Bcl-2 inhibitor

Key facts

Purity

>98%

Molecular weight

534.6 g/mol

Molecular formula

C<sub>2</sub><sub>7</sub>H<sub>3</sub><sub>8</sub>N<sub>2</sub>O<sub>9</sub>

Nature

Synthetic

Solubility

Soluble in DMSO to 10 mM

Soluble in ethanol to 10 mM

Biological description

Bcl-xL and Bcl-2 inhibitor. Antiapoptotic. Depolarizes mitochrondrial membrane potential. Reduces tumor size in vivo without toxicity.

Isomeric smiles

O=CNC1CCCC(C1OC)C(=O)N[C@@H]2C(=O)O[C@@H](C)[C@H](OC(=O)CC(C)C)[C@@H](CCCC)C(=O)O[C@@H]2C

InChi

InChI=1S/C27H38N2O9/c1-7-8-10-19-23(38-21(31)13-15(2)3)17(5)37-27(34)22(16(4)36-26(19)33)29-25(32)18-11-9-12-20(28-14-30)24(18)35-6/h9,11-12,14-17,19,22-23H,7-8,10,13H2,1-6H3,(H,28,30)(H,29,32)/t16-,17+,19-,22+,23+/m1/s1

InChiKey

CFASDUOKNNDYAT-PFQKEVSBSA-N

IUPAC Name

2-Methoxyantimycin A3

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
Store under desiccating conditions|The product can be stored for up to 12 months

Product protocols

Publications (5)

Recent publications for all applications. Explore the full list and refine your search

Immunity, inflammation and disease 11:e1102 PubMed38156384

2024

PRMT5 participates in B cell overactivation in patients with primary Sjogren's syndrome (pSS) through RSAD2-mediated NF-κB signaling.

Applications

Unspecified application

Species

Unspecified reactive species

Hong Zhu,Jian Zheng,Yan Zhou,Tong Wu,Tiantian Zhu

Science advances 8:eabm7375 PubMed35442739

2022

Efficacy and specificity of inhibitors of BCL-2 family protein interactions assessed by affinity measurements in live cells.

Applications

Unspecified application

Species

Unspecified reactive species

Elizabeth J Osterlund,Nehad Hirmiz,James M Pemberton,Adrien Nougarède,Qian Liu,Brian Leber,Qiyin Fang,David W Andrews

Bioengineered 13:7683-7696 PubMed35291915

2022

miRNA-93-5p in exosomes derived from M2 macrophages improves lipopolysaccharide-induced podocyte apoptosis by targeting Toll-like receptor 4.

Applications

Unspecified application

Species

Unspecified reactive species

Zhu Wang,Wansen Sun,Ruiping Li,Yan Liu

Journal of oncology 2021:2408384 PubMed34691176

2021

CircPTK2 (hsa_circ_0003221) Contributes to Laryngeal Squamous Cell Carcinoma by the miR-1278/YAP1 Axis.

Applications

Unspecified application

Species

Unspecified reactive species

Zhendong Yang,Jianping Jin,Tao Chang

Pharmaceutical biology 58:1229-1243 PubMed33332219

2020

Hepatoprotective effect of Xiayuxue decoction ethyl acetate fraction against carbon tetrachloride-induced liver fibrosis in mice via inducing apoptosis and suppressing activation of hepatic stellate cells.

Applications

Unspecified application

Species

Unspecified reactive species

Dingqi Zhang,Lijun Zhang,Gaofeng Chen,Ying Xu,Hailin Yang,Zhun Xiao,Jiamei Chen,Yongping Mu,Hua Zhang,Wei Liu,Ping Liu
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com